Page 8 - Human Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As antibiotic resistance increases globally, antibiotic innovation is struggling. WHO states that the antibiotic clinical pipeline is “insufficient to tackle the challenge of increasing emergence and spread of antimicrobial resistance”.1 To prevent the development of resistance, new antibiotics are used as last resort treatments and, if properly used, have small patient populations, resulting in fairly low sales revenues for industry.

CAMBRIDGE, Mass., Dec. 09, 2022Inc. (Nasdaq: BIIB) - announced that the U.S. Food and Drug Administration (FDA) has accepted for review the abbreviated Biologics License Application (aBLA) for BIIB800

CNN Editorial Research

>> we think that using what we've done before we should be able to appropriately respond to this current outbreak. >> reporter: and while the variant responsible for this particular outbreak the sudan virus does not currently have a vaccine, trials could start in four to six weeks. >> there are about six candidates, vaccine candidates, available for the sudan ebola virus which are mostly in very early stages of development, but three of them have some human data, some immunogenicity and safety data to they can proceed to be used in the field. >> reporter: the idea is to vaccinate health worker...

Biomarker testing isn’t always the standard of care for many people living with cancer today. Providers and patients need to be better...